This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weltzin, R.
Right arrow Articles by Monath, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weltzin, R.
Right arrow Articles by Monath, T. P.

 Previous Article  |  Next Article 

Infection and Immunity, May 2000, p. 2775-2782, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection

Richard Weltzin,1,* Bruno Guy,2 William D. Thomas Jr.,1 Paul J. Giannasca,1 and Thomas P. Monath1

OraVax, Inc., Cambridge, Massachusetts 02139,1 and Research Department, Pasteur Merieux Connaught, 69280 Marcy l'Etoile, France2

Received 1 July 1999/Returned for modification 22 September 1999/Accepted 4 February 2000

The heat-labile toxin (LT) of Escherichia coli is a potent mucosal adjuvant that has been used to induce protective immunity against Helicobacter felis and Helicobacter pylori infection in mice. We studied whether recombinant LT or its B subunit (LTB) has adjuvant activity in mice when delivered with H. pylori urease antigen via the parenteral route. Mice were immunized subcutaneously or intradermally with urease plus LT, recombinant LTB, or a combination of LT and LTB prior to intragastric challenge with H. pylori. Control mice were immunized orally with urease plus LT, a regimen shown previously to protect against H. pylori gastric infection. Parenteral immunization using either LT or LTB as adjuvant protected mice against H. pylori challenge as effectively as oral immunization and enhanced urease-specific immunoglobulin G (IgG) responses in serum as effectively as aluminum hydroxide adjuvant. LT and LTB had adjuvant activity at subtoxic doses and induced more consistent antibody responses than those observed with oral immunization. A mixture of a low dose of LT and a high dose of LTB stimulated the highest levels of protection and specific IgG in serum. Urease-specific IgG1 and IgG2a antibody subclass responses were stimulated by all immunization regimens tested, but relative levels were dependent on the adjuvant used. Compared to parenteral immunization with urease alone, LT preferentially enhanced IgG1, while LTB or the LT-LTB mixture preferentially enhanced IgG2a. Parenteral immunization using LT or LTB as adjuvant also induced IgA to urease in the saliva of some mice. These results show that LT and LTB stimulate qualitatively different humoral immune responses to urease but are both effective parenteral adjuvants for immunization of mice against H. pylori infection.

* Corresponding author. Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. Fax: (617) 494-0927. E-mail: rweltzin{at}oravax.com.

Infection and Immunity, May 2000, p. 2775-2782, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Agarwal, K., Agarwal, S. (2008). Helicobacter pylori Vaccine: From Past to Future. Mayo Clin Proc. 83: 169-175 [Abstract] [Full Text]  
  • Taylor, J. M., Ziman, M. E., Fong, J., Solnick, J. V., Vajdy, M. (2007). Possible Correlates of Long-Term Protection against Helicobacter pylori following Systemic or Combinations of Mucosal and Systemic Immunizations. Infect. Immun. 75: 3462-3469 [Abstract] [Full Text]  
  • Luo, Y., Wen, Y.-J., Ding, Z.-Y., Fu, C.-H., Wu, Y., Liu, J.-Y., Li, Q., He, Q.-M., Zhao, X., Jiang, Y., Li, J., Deng, H.-X., Kang, B., Mao, Y.-Q., Wei, Y.-Q. (2006). Immunotherapy of tumors with protein vaccine based on chicken homologous tie-2.. Clin. Cancer Res. 12: 1813-1819 [Abstract] [Full Text]  
  • Sommer, F., Wilken, H., Faller, G., Lohoff, M. (2004). Systemic Th1 Immunization of Mice against Helicobacter pylori Infection with CpG Oligodeoxynucleotides as Adjuvants Does Not Protect from Infection but Enhances Gastritis. Infect. Immun. 72: 1029-1035 [Abstract] [Full Text]  
  • Liu, J.-y., Wei, Y.-q., Yang, L., Zhao, X., Tian, L., Hou, J.-m., Niu, T., Liu, F., Jiang, Y., Hu, B., Wu, Y., Su, J.-m., Lou, Y.-y., He, Q.-m., Wen, Y.-j., Yang, J.-l., Kan, B., Mao, Y.-q., Luo, F., Peng, F. (2003). Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 102: 1815-1823 [Abstract] [Full Text]  
  • Eisenberg, J. C., Czinn, S. J., Garhart, C. A., Redline, R. W., Bartholomae, W. C., Gottwein, J. M., Nedrud, J. G., Emancipator, S. E., Boehm, B. B., Lehmann, P. V., Blanchard, T. G. (2003). Protective Efficacy of Anti-Helicobacterpylori Immunity following Systemic Immunization of Neonatal Mice. Infect. Immun. 71: 1820-1827 [Abstract] [Full Text]  
  • Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A. M., Lewis, S., Turner, A. K., Rees, E. L., Tibbitts, T. J., Greenwood, J., Monath, T. P., Darsley, M. J. (2002). Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen. Infect. Immun. 70: 5096-5106 [Abstract] [Full Text]  
  • Ghaem-Maghami, M., Simmons, C. P., Daniell, S., Pizza, M., Lewis, D., Frankel, G., Dougan, G. (2001). Intimin-Specific Immune Responses Prevent Bacterial Colonization by the Attaching-Effacing Pathogen Citrobacter rodentium. Infect. Immun. 69: 5597-5605 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»